Federal Register / Vol. 73, No. 26 / Thursday, February 7, 2008 / Notices 7311 

dockets/ac/acmenu.htm, click on the 

year 2008 and scroll down to the 

appropriate advisory committee link. 

Procedure: On March 4, 2008, from 8 

a.m. to 5:30 p.m., and on March 5, 2008, 

from 8:30 a.m. to 5 p.m., the meeting is 

open to the public. Interested persons 

may present data, information, or views, 

orally or in writing, on issues pending 

before the committee. Written 

submissions may be made to the contact 

person on or before February 19, 2008. 

Oral presentations from the public will 

be scheduled between approximately 10 

a.m. and 10:30 a.m., and between 3:15 

p.m. and 3:45 p.m. on March 4, 2008, 

and between approximately 9:10 a.m. 

and 9:40 a.m., and between 2:15 p.m. 

and 2:45 p.m. on March 5, 2008. Those 

desiring to make formal oral 

presentations should notify the contact 

person and submit a brief statement of 

the general nature of the evidence or 

arguments they wish to present, the 

names and addresses of proposed 

participants, and an indication of the 

approximate time requested to make 

their presentation on or before February 

11, 2008. Time allotted for each 

presentation may be limited. If the 

number of registrants requesting to 

speak is greater than can be reasonably 

accommodated during the scheduled 

open public hearing session, FDA may 

conduct a lottery to determine the 

speakers for the scheduled open public 

hearing session. The contact person will 

notify interested persons regarding their 

request to speak by February 12, 2008. 

Closed Presentation of Data: On 

March 5, 2008, from 8 a.m. to 8:30 a.m., 

the meeting will be closed so that the 

committee may receive an update from 

FDA about devices under evaluation 

that may be brought before the 

committee in the near future. This 

portion of the meeting will be closed 

because it involves the discussion and 

review of trade secret and/or 

confidential information (5 U.S.C. 

552b(c)(4)). 

Persons attending FDA’s advisory 

committee meetings are advised that the 

agency is not responsible for providing 

access to electrical outlets. 

FDA welcomes the attendance of the 

public at its advisory committee 

meetings and will make every effort to 

accommodate persons with physical 

disabilities or special needs. If you 

require special accommodations due to 

a disability, please contact Shirley 

Meeks, Conference Management Staff, at 

240–276–8931, at least 7 days in 

advance of the meeting. 

FDA is committed to the orderly 

conduct of its advisory committee 

meetings. Please visit our Web site at 

http://www.fda.gov/oc/advisory/ 

default.htm for procedures on public 

conduct during advisory committee 

meetings. 

Notice of this meeting is given under 

the Federal Advisory Committee Act (5 

U.S.C. app. 2). 

Dated: January 28, 2008. 

Randall W. Lutter, 

Deputy Commissioner for Policy. 

[FR Doc. E8–2265 Filed 2–6–08; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Human 

Genome Research Institute Special Emphasis 

Panel, T32 Application. 

Date: March 6, 2008. 

Time: 12 p.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5635 

Fishers Lane, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Rudy O. Pozzatti, PhD, 

Scientific Review Officer, Scientific Review 

Branch, National Human Genome Research 

Institute, 5635 Fishers Lane, Suite 4076, MSC 

9306, Rockville, MD 20852, (301) 402–0838, 

pozzattr@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Nos. 93.172, Human Genome Research, 

National Institutes of Health, HHS) 

January 31, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–520 Filed 2–6–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. the grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group, Neurological Sciences and 

Disorders B. 

Date: February 28–29, 2008. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Admiral Fell Inn, Historic Fell’s 

Point, 888 South Broadway, Baltimore, MD 

21231. 

Contact Person: W. Ernest Lyons, PhD, 

Scientific Review Officer, Scientific Review 

Branch NINDS/NIH/DHHS, Neuroscience 

Center, 6001 Executive Blvd., Suite 3208, 

MSC 9529, Bethesda, MD 20892–9529, 301–

496–4056. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group, Neurological Science and 

Disorders K. 

Date: March 3–4, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Fairmont Washington, DC, 2401 

M Street, NW., Washington, DC 20037. 

Contact Person: Shanta Rajaram, PhD, 

Scientific Review Officer, Division of 

Extramural Research, NIH/NIND/SRB, 

Neuroscience Center, 6601 Executive Blvd., 

Suite 3208, MSC 9529, Bethesda, MD 20852, 

(301) 435–6033, rajarams@mail.nih.gov. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group, Neurological Sciences and 

Disorders A. 

Date: March 5–6, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Portofino Hotel, 260 Portofino 

Way, Redondo Beach, CA 90277. 

Contact Person: Richard D. Crosland, PhD, 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Research, 


jlentini on PROD1PC65 with NOTICES
7312 Federal Register / Vol. 73, No. 26 / Thursday, February 7, 2008 / Notices 

NINDS/NIH/DHHS, Neuroscience Center, 

6001 Executive Blvd. Suite 3208, MSC 9529, 

Bethesda, MD 20892–9529, 301–596–9223. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group, Neurological Sciences and 

Disorders C. 

Date: March 6–7, 2008. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Melrose Hotel, Washington, 

DC., 2430 Pennsylvania Avenue, NW., 

Washington, DC 20037. 

Contact Person: William C. Benzing, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, Division of Extramural 

Research, NINDS/NIH/DHHS/Neuroscience 

Center, 6001 Executive Boulevard, Suite 

3208, MSC 9529, Bethesda, MD 20892, (301) 

496–0660, benzingw@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853. Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: January 31, 2008. 

Jennifer Spaeth, 

Director of Federal Advisory Committee 

Policy. 

[FR Doc. 08–517 Filed 2–6–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Child Health and 

Human Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel, Diagnostic and 

Pharmacokinetic Research in Pediatric HIV/ 

TB and Effects of Co-Infection on the Central 

Nervous System (R01). 

Date: March 3, 2008. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Hilton, 620 Perry 

Parkway, Gaithersburg, MD 20877. 

Contact Person: Sathasiva B. Kandasamy, 

PhD, Scientific Review Administrator, 

Division of Scientific Review, National 

Institutes of Child Health, and Human 

Development, 6100 Executive Boulevard, 

Room 5B01, Bethesda, MD 20892–9304, 301–

435–6680, skandasa@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS). 

Dated: January 31, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–519 Filed 2–6–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and person information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Molecular 

Biology of Pathogens. 

Date: February 18, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Rolf Menzel, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3196, 

MSC 7808, Bethesda, MD 20892, 301–435–

0952, menzelro@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, PAR07–131: 

Pharmacogenetics of Fluoride. 

Date: February 26, 2008. 

Time: 12 p.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: J. Terrell Hoffeld, DDS, 

PhD, Dental Officer, USPHS, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4116, 

MSC 7816, Bethesda, MD 20892, 301–435–

1781, th88q@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Innate 

Immunity Overflow Meeting. 

Date: February 28–29, 2008. 

Time: 11 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Samuel C. Edwards, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4200, 

MSC 7812, Bethesda, MD 20892, 301–435–

1152, edwardss@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, DBBD 

Diversity Predoctoral Fellowship Review. 

Date: March 4–5, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Paek-Gyu Lee, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4095D, 

MSC 7812, Bethesda, MD 20892, 301–402–

7391, leepg@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Diversity 

Fellowships in Molecular and Cellular 

Mechanisms. 

Date: March 6–7, 2008. 

Time: 8 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville Pike, Rockville, MD 

20852. 

Contact Person: Barbara J. Thomas, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2218, 

MSC 7890, Bethesda, MD 20892, 301–435–

0603, bthomas@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Biomedical 

Mass Spectrometry Shared Instrumentation 

Review Panel. 

Date: March 12–14, 2008. 

Time: 7 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 


jlentini on PROD1PC65 with NOTICES